SCHEMBL6931984

SCHEMBL6931984

Cc1c[c]ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(Cl)cc(C#N)c1

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 3/20 0.65
▸ KCNH2 Q12809 3/20 0.51
▸ TP53 P04637 4/20 0.45
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ THRB P10828 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CETP P11597 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6933170 0.90 SLC2A1 (0.68) SLC2A1KCNH2TP53MAPTSMN1; SMN2
SCHEMBL6933529 0.84 SLC2A1 (0.57) SLC2A1KCNH2TP53MAPTSMN1; SMN2
SCHEMBL5623473 0.84 SLC2A1 (0.65) SLC2A1KCNH2TP53MAPTSMN1; SMN2
SCHEMBL30601627 0.84 SLC2A1 (0.65) SLC2A1KCNH2TP53MAPTSMN1; SMN2
SCHEMBL5891717 0.82 SLC2A1 (0.63) SLC2A1KCNH2TP53MAPTSMN1; SMN2
SCHEMBL6933526 0.82 SLC2A1 (0.68) SLC2A1KCNH2TP53MAPTSMN1; SMN2
SCHEMBL5891404 0.82 SLC2A1 (0.62) SLC2A1KCNH2TP53MAPTSMN1; SMN2
Gw-695634 SCHEMBL29403521 0.81 SLC2A1 (0.61) SLC2A1KCNH2TP53MAPTSMN1; SMN2
Gw-695634 SCHEMBL5891791 0.81 SLC2A1 (0.61) SLC2A1KCNH2TP53MAPTSMN1; SMN2
Gw-695634 SCHEMBL5891100 0.81 SLC2A1 (0.61) SLC2A1KCNH2TP53MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363877-A2 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE SmithKline Beecham Corporation (US) 2003-11-26 — — EP claimed
WO-2002070470-A2 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE SMITHKLINE BEECHAM CORPORATION (US) 2002-09-12 — — WO claimed
EP-1363877-A2 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE SmithKline Beecham Corporation (US) 2003-11-26 — — EP disclosed
WO-2002070470-A2 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE SMITHKLINE BEECHAM CORPORATION (US) 2002-09-12 — — WO disclosed
Send feedback